UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 161 filers reported holding CYTOKINETICS INC in Q2 2020. The put-call ratio across all filers is 1.54 and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q2 2024$13,650,217
+65.1%
251,942
+113.7%
0.00%
+33.3%
Q1 2024$8,267,512
-15.0%
117,922
+1.2%
0.00%
-25.0%
Q4 2023$9,732,011
+173.4%
116,565
-3.5%
0.00%
+100.0%
Q3 2023$3,560,065
-12.4%
120,844
+4.6%
0.00%0.0%
Q2 2023$4,066,0640.0%115,5460.0%0.00%0.0%
Q1 2023$4,066,064
-8.8%
115,546
+18.8%
0.00%0.0%
Q4 2022$4,457,921
-99.9%
97,292
+19.0%
0.00%0.0%
Q3 2022$3,962,193,000
+1.4%
81,779
-17.8%
0.00%0.0%
Q2 2022$3,907,391,000
+13.4%
99,450
+6.2%
0.00%
+100.0%
Q1 2022$3,446,998,000
-19.7%
93,643
-0.6%
0.00%
-50.0%
Q4 2021$4,292,178,000
+73.0%
94,168
+35.7%
0.00%
+100.0%
Q3 2021$2,480,713,000
+99.2%
69,410
+10.3%
0.00%0.0%
Q2 2021$1,245,483,000
-15.6%
62,935
-0.8%
0.00%0.0%
Q1 2021$1,475,079,000
+32.5%
63,417
+18.4%
0.00%0.0%
Q4 2020$1,113,288,000
-2.8%
53,575
+1.2%
0.00%0.0%
Q3 2020$1,145,891,000
+0.4%
52,928
+9.3%
0.00%0.0%
Q2 2020$1,140,999,000
+63.0%
48,409
-18.4%
0.00%0.0%
Q1 2020$699,867,000
+41.3%
59,361
+27.2%
0.00%
Q4 2019$495,286,000
-24.9%
46,681
-19.5%
0.00%
Q3 2019$659,722,000
+102.0%
57,972
+99.7%
0.00%
Q2 2019$326,520,000
+39.1%
29,0240.0%0.00%
Q1 2019$234,804,000
+41.8%
29,024
+10.8%
0.00%
Q4 2018$165,584,000
-35.8%
26,2000.0%0.00%
Q3 2018$258,070,000
+18.7%
26,2000.0%0.00%
Q2 2018$217,460,00026,2000.00%
Other shareholders
CYTOKINETICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
BVF INC/IL 5,721,888$46,633,0005.62%
IRONWOOD INVESTMENT MANAGEMENT LLC 107,139$873,0000.62%
Virtus ETF Advisers LLC 42,645$348,0000.44%
SPHERA FUNDS MANAGEMENT LTD. 210,000$1,712,0000.20%
LANSDOWNE PARTNERS (UK) LLP 2,647,981$21,581,0000.20%
WASATCH ADVISORS LP 1,679,778$13,690,0000.18%
PINNACLE ASSOCIATES LTD 877,575$7,152,0000.14%
ESSEX INVESTMENT MANAGEMENT CO LLC 107,728$878,0000.12%
Tekla Capital Management LLC 350,300$2,855,0000.11%
Financial Gravity Companies, Inc. 9,302$86,0000.10%
View complete list of CYTOKINETICS INC shareholders